Clear predictors of changing insulin requirements & A1C in youth with type 1 diabetes

June 05, 2018

BOSTON - (June 9, 2018) - Managing type 1diabetes during the first two decades of life is challenging. Insulin requirements change along with the stages of life --- childhood, puberty, young adulthood, and beyond. But a 20-year longitudinal study conducted by researchers from Joslin Diabetes Center and Harvard Medical School identifies clear predictors of rising A1C levels in young persons, as well as ways to improve glycemic control in this population. The study has been published online by Diabetic Medicine.

Poor glycemic control and deteriorating A1C levels are common in children and adolescents with type 1 diabetes, says study senior author Lori Laffel, MD, MPH, Chief of the Pediatric, Adolescent and Young Adult Section and the Section on Clinical, Behavioral and Outcomes Research at Joslin Diabetes Center. "Fewer than one in five children and adolescents with type 1diabetes achieves target A1C levels."

For this study, researchers evaluated two trajectories --- insulin doses and A1C levels --- over time in 635 young persons (ages 7 to 24) with type 1 diabetes. Insulin dose data and A1C data were collected over a 20-year period. Researchers assessed insulin dose and glycemic control by sex, insulin regimen (pump versus injection therapy), and weight status (normal versus overweight/obese). The clinical factors associated with glycemic changes over time were also identified.

Researchers discovered that during late adolescence and young adulthood (ages 16 to 24), A1C levels were higher in females than males. Additionally, insulin doses were higher in females than in males at younger ages, between ages 8 and 13, but doses were higher in males than females between ages 16 and 21.

"We need to attend to the glycemic deterioration that emerges in the second half of the teen years and early 20s, especially among female patients," says Dr. Laffel. "The study confirms the notion that we may need to give more insulin to females during the periods when A1C levels are rising, or address other aspects of diabetes care, such as diet and exercise in efforts to improve A1C levels."

The study also showed that insulin pump users compared with injection treated patients required lower insulin doses and had lower A1C levels over time. "Insulin delivered by a pump may control glycemia in a more effective manner, with a lower insulin dose. Alternatively, persons using an insulin pump may find it easier to attend to their diabetes self-care in a timely manner, leading to better glycemic control with lower insulin doses," says Dr. Laffel.

Finally, there was no difference in A1C levels between overweight/obese and normal weight patients. However, overweight and obese youth were taking higher insulin doses between ages 8 and 13. "These findings suggest that the insulin resistance, which generally occurs in association with pubertal growth and development, may develop at younger ages when youth are overweight or obesity. Clinicians can be more proactive in adjusting insulin doses in order to prevent A1C deterioration for these youth," says Dr. Laffel.

Unique to this study is the rigorously collected data in large number of patients, which allowed researchers to look at these trajectories across many developmental stages. This new research highlights how clinicians can optimize glycemic control across childhood, adolescence, and young adulthood.

"We want to use these research observations along with currently available advanced diabetes technologies to improve glucose control and optimize health outcomes for our young patients," says Dr. Laffel. "The results of this study give further evidence of the need to be more aggressive in increasing insulin doses in a timely manner to combat that rise in A1C levels seen during childhood and adolescence."
-end-
Other study authors include Gabriela H. Telo, MD, PhD, Carly E. Dougher, MPH, Lisa K. Volkening, MA, and Michelle L. Katz, MD, MPH.

Citation: Predictors of Changing Insulin Dose Requirements and Glycemic Control in Children, Adolescents, and Young Adults with Type 1 Diabetes. Diabetic Medicine. June 5, 2018 [online]

Joslin Diabetes Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.